Science in Sport (SISS.L, SIS LN)
- 24.6
- 172.4
- 90.0
Company Profile
Science in Sport is an active lifestyle nutrition platform that operates a dual brand strategy across endurance and lifestyle verticals. Its brands include SiS, a leading endurance nutrition portfolio, and PhD, a leading protein brand family that is expanding into further functional adjacencies. It is a niche player with a premium product offering, anchored by strong internal sports science credentials and a unique innovation model. It operates an omni-channel model, with digital channels comprising 56% of sales. It holds strong market positions domestically (the UK comprises 60% of sales) with strong international growth across Europe, Asia and the US (40% of sales). Its medium-term targets are for £100m of sales and double-digit adjusted EBITDA margins. It is separately targeting 70% of sales from the online and international channels. In FY 2021, it reported revenue of £62.7m and an adjusted EBITDA of £2.2m.
Major Shareholders | % |
Lombard Odier Asset Mgt. (Europe) | 21.0 |
J.O. Hambro Capital Mgt. Ltd. | 8.9 |
Aviva Investors Global Services. | 8.5 |
Otus Capital Management Ltd. | 8.2 |
River & Mercantile Asset Mgt. LLP | 7.0 |